Nebulayzery dlya dlitel'noy podderzhivayushchey terapii obstruktivnykh zabolevaniy legkikh
- Authors: Avdeev S.N1
-
Affiliations:
- ФГУ НИИ Пульмонологии ФМБА России
- Issue: Vol 10, No 10 (2008)
- Pages: 34-41
- Section: Articles
- URL: https://journal-vniispk.ru/2075-1753/article/view/92769
- ID: 92769
Cite item
Abstract
Залогом успешной ингаляционной терапии является не только правильный выбор препарата, но и такие факторы, как обучение ингаляционной технике пациента, выбор оптимальной системы доставки препарата [2]. Идеальное устройство доставки должно обеспечивать достаточно высокую депозицию (оседание) препарата в легких, быть надежным и простым в использовании, доступным для применения в любом возрасте и при тяжелых стадиях заболевания. К основным типам систем доставки относятся дозированные аэрозольные ингаляторы (ДАИ), дозированные порошковые ингаляторы (ДПИ) и небулайзеры.
Full Text
##article.viewOnOriginalSite##References
- Tashkin D.P. The Role of Nebulizers in Airways Disease Management. Touch Briefings 2007; 27–31.
- Cochrane M.G, Bala M.V, Downs K.E et al. Inhaled corticosteroids for asthma therapy. Patient compliance, devices, and inhalation technique. Chest 2000; 117: 542–50.
- Huchon G. Metered dose inhalers part and present: advantages and limitations. Eur Respir Rev 1997; 7 (41): 26–8.
- Borgstrom L, Bisgaard H, O'Callaghan C, Pedersen S. Dry - powder inhalers. Ed: Bisgaard H, O'Callaghan C, Smaldone G. Drug delivery to the lung. New York: Marcel Dekker, Inc. 2002; 421–48.
- Newman S.P, Busse W.W. Evolution of dry powder inhaler design, formulation, and performance. Respir Med 2002; 96: 293–304.
- Lavorini F, Magnan A, Dubus J.C et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008; 102: 593–604.
- Авдеев С.Н. Устройства доставки ингаляционных препаратов, используемые при терапии заболеваний дыхательных путей. Рус. мед. журн. 2002; 10 (5): 255–61.
- Boe J, Dennis J.H, O'Driscoll B.R et al. European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J 2001; 18: 228–42.
- Dhand R. Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care 2002; 47: 1406–18.
- Vecellio L. The mesh nebulizer: a recent technical innovation for aerosol delivery. Breathe 2006; 2: 253–60.
- Knoch M, Keller M. The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems. Expert Opin Drug Deliver 2005; 2: 377–90.
- Newman S, Gee-Turner A. The Omron MicroAir vibrating mesh technology nebuliser, a 21st century approach to inhalation therapy. J Appl Ther Res 2005; 5: 429–33.
- Чучалин А.Г., Княжеская Н.П., Потапова М.О. «Место небулайзеров в ингаляционной терапии хронических обструктивных заболеваний лёгких». Рус. мед. журн. 2006; 14(7).
- Dennis J, Pieron C, Gee-Turner A et al. Omron VVT Nebulizer Performance. J Aerosol Med 2007; 20: 365–92.
- Dolovich M.B, Ahrens R.C, Hess D.R et al. Device selection and outcomes of aerosol therapy: Evidence - based guidelines. Chest 2005; 127: 335–71.
- British Thoracic Society Nebuliser Project Group. Current best practice for nebuliser treatment. Thorax 1997; 52 (Suppl. 2): S1–S24.
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2006, National Institutes of Health/WHO. Available fromhttp://www.goldcopd.com.
- ERS Task Force. European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J 2001; 18: 228–42.
- O'Driscoll B.R, Kay E.A, Taylor R.J et al. A long - term prospective assessment of home nebulizer treatment. Respir Med 1992; 86: 317–25.
- Goldman J.M, Teale C, Muiers M.F. Simplifying the assessment of patients with chronic airflow limitation for home nebulizer therapy. Respir Med 1992; 86: 33–8.
- Morrison J.F.J, Jones P.C, Muers M.F. Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation. Eur Respir J 1992; 5: 424–9.
- Barta S, Crawford A, Roberts C. Survey of patients' views of domiciliary nebuliser treatment for chronic lung disease. Respir Med 2002; 96: 375–81.
- Marcus P, Oppenheimer E.A, Patel P.A et al. Use of nebulized inhaled corticosteroids among older adult patients: an assessment of outcomes. Ann Allergy Asthma Immunol 2006; 96: 736–43.
- Tashkin D, Klein G, Colman S.S et al. Comparing COPD treatment: nebulizer, metered dose inhaler and concomitant therapy. Am J Med 2007; 120: 435–41.
Supplementary files
